ALS News & Research For postings of news or research links and articles related to ALS


advertisement
Reply
 
Thread Tools Display Modes
Old 05-18-2017, 11:26 AM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
Exclamation CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS | P&T Community
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Old 05-18-2017, 11:27 AM #2
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
Exclamation Target ALS Foundation, award grant to CRISPR Therapeutics AG (NASDAQ:CRSP) to support

Target ALS Foundation, award grant to CRISPR Therapeutics AG (NASDAQ:CRSP) to support CRISPR/Cas9-based therapeutic approaches

Target ALS Foundation, award grant to CRISPR Therapeutics AG (NASDAQ:CRSP) to support CRISPR/Cas9-based therapeutic approaches | Benchmark Monitor
MuonOne is offline   Reply With QuoteReply With Quote
Old 05-18-2017, 11:38 AM #3
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
Exclamation CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS

CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS - News Press Release | PharmiWeb.com

NOTE: CRISPR is very recent biological development . . . and widely seen as Nobel prize candidate:

CRISPR loses Nobel to tiny machines
CRISPR loses Nobel to tiny machines | TechCrunch

Eric Lander talks CRISPR and the infamous Nobel ‘rule of three’
Eric Lander talks CRISPR and the infamous Nobel ‘rule of three’ - The Washington Post

they are already interested in amazing Amyotrophic Lateral Sclerosis applications?!
MuonOne is offline   Reply With QuoteReply With Quote
Old 05-18-2017, 11:40 AM #4
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,268
15 yr Member
Lightbulb Crispr

CRISPR

CRISPR - Wikipedia
MuonOne is offline   Reply With QuoteReply With Quote
Reply

Tags
als, crispr, florida, target, university


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Karyopharm and Collaborators Awarded Grant for ALS Research MuonOne ALS News & Research 0 12-23-2016 08:30 AM
Addex Therapeutics Awarded $1 MM Grant from The MJFF for Parkinson's Research sim00 Parkinson's Disease 0 03-19-2013 04:02 PM


All times are GMT -5. The time now is 02:38 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.